MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Overview Fund Activity
Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

221 hedge funds and large institutions have $2.38B invested in Mirati Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 88 increasing their positions, 65 reducing their positions, and 41 closing their positions.

Holders
221
Holders Change
-12
Holders Change %
-5.15%
% of All Funds
3.54%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.11%
New
31
Increased
88
Reduced
65
Closed
41
Calls
$16.7M
Puts
$10.6M
Net Calls
+$6.03M
Net Calls Change
-$46.1M

Top Buyers

1
BlackRock
1
BlackRock
New York
$120M
2
Marshall Wace
2
Marshall Wace
United Kingdom
$20.5M
3
Voloridge Investment Management
3
Voloridge Investment Management
Florida
$25.2M
4
Morgan Stanley
4
Morgan Stanley
New York
$76.3M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$65.8M

Top Sellers

1
Ameriprise
1
Ameriprise
Minnesota
$0
2
PA
2
Perceptive Advisors
New York
$58.5M
3
California Public Employees Retirement System
3
California Public Employees Retirement System
California
$2.58M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$716K
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$6.62M
Name Market Value Shares Shares
Change 		Shares
Change %
ACA
1
Avoro Capital Advisors
New York
$207M 5,555,555 – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$188M 5,049,375 +75,487 +2%
AC
3
Armistice Capital
New York
$137M 3,692,000 +204,000 +6%
RI
4
RTW Investments
New York
$135M 3,643,114 – –
BlackRock
5
BlackRock
New York
$120M 3,236,879 +573,957 +22%
AH
6
Aviva Holdings
Bahamas
$117M 3,135,966 – –
Wellington Management Group
7
Wellington Management Group
Massachusetts
$100M 2,696,092 -320,243 -11%
State Street
8
State Street
Massachusetts
$85.9M 2,309,820 -235,756 -9%
Morgan Stanley
9
Morgan Stanley
New York
$76.3M 2,051,453 +361,742 +21%
BC
10
Boxer Capital
California
$74.4M 2,000,000 – –
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$65.8M 1,770,941 +354,213 +25%
PA
12
Perceptive Advisors
New York
$58.5M 1,574,134 -617,291 -28%
AG
13
Artal Group
Luxembourg
$57.2M 1,537,709 -295,049 -16%
BBA
14
Baker Bros. Advisors
New York
$52.4M 1,409,784 – –
CCM
15
Camber Capital Management
Massachusetts
$52.1M 1,400,000 – –
PBA
16
Paradigm Biocapital Advisors
New York
$51.9M 1,396,779 +128,809 +10%
RSCM
17
Rock Springs Capital Management
Maryland
$39.6M 1,065,261 +260,237 +32%
O
18
OrbiMed
New York
$34M 913,650 -370,042 -29%
OCA
19
Octagon Capital Advisors
New York
$27.9M 750,000 – –
Geode Capital Management
20
Geode Capital Management
Massachusetts
$27.3M 735,288 +27,943 +4%
Fiera Capital (Canada)
21
Fiera Capital (Canada)
Quebec, Canada
$26.4M 709,527 +16,870 +2%
CS
22
Candriam SCA
Luxembourg
$26.2M 764,265 -3,331 -0.4%
Voloridge Investment Management
23
Voloridge Investment Management
Florida
$25.2M 678,658 +524,038 +339%
Norges Bank
24
Norges Bank
Norway
$24.4M 657,238 +181,246 +38%
Franklin Resources
25
Franklin Resources
California
$24.3M 652,368 -84,400 -11%
1
2 3 4 5